Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203775 · ClinicalTrials.gov registry record · NA
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
A NA study, sponsored by University of Connecticut.
- Terminated
- Registry status
- NA
- Development phase
NCT00203775: Clinical Trial NA study, sponsored by University of Connecticut.
NCT00203775 is a NA study that was terminated before completion, run by University of Connecticut. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00203775, a NA study, was terminated before completion, sponsored by University of Connecticut.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
Interventions
- DRUG risperidone
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-07 |
| Est. Completion | 2004-04 |
| Phase | NA |
Why NCT00203775 stopped before completion
NCT00203775 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which risperidone is the first listed.
NCT00203775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00203775 about?
NCT00203775 is a clinical study titled "Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates". This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
What is the current status of trial NCT00203775?
This trial is currently terminated. It is a NA study. The study started on 2002-07. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00203775?
The interventions under investigation include: risperidone (DRUG).
Who is sponsoring clinical trial NCT00203775?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia